Jurors in Elizabeth Holmes case end fourth day without verdict

Founder of failed blood-testing startup Theranos faces 11 counts of fraud

Elizabeth Holmes, the founder and former CEO of blood testing and life sciences company Theranos.
Elizabeth Holmes, the founder and former CEO of blood testing and life sciences company Theranos.

Jurors ended a fourth day of deliberations without a verdict on Monday in the fraud trial of Elizabeth Holmes, founder of failed blood-testing startup Theranos.

Ms Holmes, 37, faces 11 counts of wire fraud and conspiracy to commit wire fraud over charges that she lied about Theranos’ technology as she sought investments and business for her startup. If convicted, she faces up to 20 years in prison for each count of wire fraud.

A jury of eight men and four women also deliberated Dec. 20, Dec. 21 and Thursday. They are scheduled to return to federal court here at 8:30 a.m. Tuesday to resume deliberations.

On Thursday, they asked to hear recordings of a call Holmes had with investors, in which she allegedly made misleading claims about Theranos’ partnerships with pharmaceutical companies and the military. The jurors’ deliberations follow a nearly four-month trial that is viewed as a referendum on the worst excesses of Silicon Valley’s startup culture.

READ SOME MORE

Before Theranos collapsed, Holmes was a highly celebrated female founder. She dropped out of Stanford University at age 19 to focus on her company and spent the next decade raising nearly $1 billion (€888 million) from investors.

Investigation

In 2015, Theranos began to unravel after a Wall Street Journal investigation revealed that the company had relied on commercially available machines to perform many of its blood tests, rather than its own supposedly revolutionary devices. Theranos shut down in 2018, the same year Ms Holmes was indicted.

During the trial, federal prosecutors have tried to prove that Ms Holmes intentionally deceived investors, patients and commercial partners by forging validation reports, faking demonstrations and misrepresenting Theranos to the media and the public.

“She chose fraud over business failure,” Jeffrey Schenk, an assistant US attorney, said during the government’s closing argument. Ms Holmes, who took the stand for seven days in her own defense, has tried painting herself as a well-meaning entrepreneur who believed her own claims and was led astray by those around her.

“She believed she was building a technology that would change the world,” said Kevin Downey, a lawyer for Ms Holmes.

This article originally appeared in The New York Times